|
QuintilesIMS Real-World Insights Bibliography
| Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature. |
| Author(s): Svedman FC1, Pillas D2, Taylor A2, Kaur M2, Linder R3, Hansson J1. |
| Affiliations(s): 1Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden.
2Centre for Observational Research, Amgen Ltd, Uxbridge, UK.
3IMS Health Sweden, Stockholm, Sweden.
|
| Publication(s): Clinical Epidemiology |
| Document Type(s): Article |
| Countries: Australia, Austria, Belgium, Bulgaria, Croatia, Czech, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Israel, Italy, Netherlands, Norway, Poland, Portugal, Russian Federation, Serbia and Montenegro, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, UK |
| Click here for the abstract |
C:
Y: |
Oncology
2016 |
|
L:
A: |
English
Literature Review |
|
 |
| |
| |
| Rationale and design of a multi-center survey to evaluate productivity losses and indirect costs after cardiovascular events in Europe. |
| Author(s): Gerlier L1, Sidelnikov E2, Kutikova L2, Lamotte M1, Annemans L3 |
| Affiliations(s): 1 QuintilesIMS, Zaventem, Belgium 2 Amgen (Europe) GmbH, Zug, Switzerland 3 University of Ghent, Ghent, Belgium |
| Publication(s): 19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria |
| Document Type(s): Abstract |
| Countries: Belgium, Czech, France, Germany, Hungary, Italy, Poland, Portugal, Romania, Spain, Switzerland, UK |
C:
Y: |
Cardiovascular disease
2016 |
|
L:
A: |
English
|
|
|
| |
| |
| Liver transplant associated with paracetamol overdose: results from the seven-country SALT study |
| Author(s): Sinem Ezgi Gulmez,1 Dominique Larrey,2 Georges-
Philippe Pageaux,2 Jacques Bernuau,3 Franco Bissoli,4
Yves Horsmans,5 Douglas Thorburn,6 P. Aiden McCormick,7
Bruno Stricker,8 Massoud Toussi,9 Séverine Lignot-Maleyran,1
Sophie Micon,1 Fatima Hamoud,1 Régis Lassalle,1 Jérémy Jové,1
Patrick Blin1 & Nicholas Moore1 |
| Affiliations(s): 1CIC Bordeaux CIC1401 Pharmaco-épidémiologie, Université de Bordeaux, F-33076 Bordeaux,
France, 2CHU St Eloi Hospital, Liver Unit, Montpellier, France, 3Beaujon Hospital, Liver Unit, Clichy,
France, 4Department of Internal Medicine, Clinica San Gaudenzio, Novara, Italy, 5Department of
Gastroenterology, Louvain Catholic University, Louvain, Belgium, 6Liver Unit, Royal Free NHS Trust,
London, UK, 7Liver Unit, St Vincent’s University Hospital and University College Dublin, Dublin,
Ireland, 8Department of Epidemiology, Erasmus University, Rotterdam, Netherlands and 9IMSHealth, Real World Evidence Solutions, France |
| Publication(s): British Journal of Clinical Pharmacology 2015 |
| Document Type(s): Article |
| Countries: France, Greece, Ireland, Italy, Netherlands, Portugal, UK |
C:
Y: |
Drug safety, Public Health
2015 |
|
L:
A: |
English
Epidemiological study |
|
|
| |
| |
| Survey on appropriateness of use of nimesulide in nine European countries |
| Author(s): Franchi S1, Heiman F2, Visentin E2, Sacerdote P1. |
| Affiliations(s): 1Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milan, Italy.
2Cegedim Strategic Data Medical Research Srl, Milan, Italy. |
| Publication(s): Drug, Healthcare and Patient Safety 2015:7 51-55 |
| Document Type(s): Article |
| Countries: Bulgaria, Czech, Greece, Hungary, Italy, Poland, Portugal, Romania, Slovakia |
C:
Y: |
Pain
2015 |
|
L:
A: |
English
Survey research |
|
|
| |
| |
| Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study. |
| Author(s): Emery P1, Gottenberg JE2, Rubbert-Roth A3, Sarzi-Puttini P4, Choquette D5, Taboada VM6, Barile-Fabris L7, Moots RJ8, Ostor A9, Andrianakos A10, Gemmen E11, Mpofu C12, Chung C13, Gylvin LH12, Finckh A14. |
| Affiliations(s): 1Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Leeds, UK NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
2Department of Rheumatology, CHU Strasbourg, Strasbourg, France.
3University of Cologne, Cologne, Germany.
4L Sacco University Hospital, Milan, Italy.
5University of Montreal, Montreal, Canada.
6Facultad de Medicina, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, Santander, Spain.
7Hospital de Especialidades Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, México City, Mexico.
8Department of Rheumatology, University of Liverpool, Liverpool, UK.
9Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
10Hellenic Foundation for Rheumatological Research, Athens, Greece.
11Quintiles, Rockville, Maryland, USA.
12F Hoffmann-La Roche Ltd, Basel, Switzerland.
13Genentech Inc, San Francisco, California, USA.
14University Hospital of Geneva, Geneva, Switzerland. |
| Publication(s): Ann Rheum Dis. 2015 Jun;74(6):979-84 |
| Document Type(s): Article |
| Countries: Canada, Colombia, France, Germany, Greece, Italy, Mexico, Norway, Portugal, Spain, UK |
| Click here for the abstract |
C:
Y: |
Comparative Effectiveness & Health Technology Assessment, Rheumatology
2015 |
|
L:
A: |
English
Clinical setting: hospital, clinical setting: Secondary care, Prospective study, RWLPR (Real-World Late Phase Research-quintiles |
|
|
| |
| |
| Cost-effectiveness of rivaroxaban for stroke prevention in atrial fibrillation in the Portuguese setting |
| Author(s): Morais J1, Aguiar C2, McLeod E3, Chatzitheofilou I3, Fonseca Santos I4, Pereira S4 |
| Affiliations(s): 1 Hospital de Santo André, CHLP, Leiria, Portugal 2 Hospital de Santa Cruz, CHLO, Carnaxide, Portugal 3 IMS Health, London, UK 4 Bayer Portugal, S.A., Carnaxide, Portugal |
| Publication(s): Portuguese Journal of Cardiology, In Press |
| Document Type(s): Article |
| Countries: Portugal |
C:
Y: |
Cardiovascular disease
2014 |
|
L:
A: |
English
Cost effectiveness |
|
|
| |
| |
| Health economic evaluation of canagliflozin in the treatment of type 2 diabetes mellitus in Portugal |
| Author(s): Troelsgaard A1, Knudsen M2, Maia-Lopes S3, Luz M3, Hemels M1
|
| Affiliations(s): 1Janssen A/S, Birkerød, Denmark, 2IMS Health, Hellerup, Denmark, 3Janssen-Cilag Farmacêutica, Barcarena, Portugal |
| Publication(s): ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
| Document Type(s): Poster |
| Countries: Portugal |
C:
Y: |
Diabetes
2014 |
|
L:
A: |
English
Economic evaluation |
|
|
| |
| |
| Cost analysis of anemia treatment with erythropoieses-stimulating agents (ESAs) in patients with cancer receiving chemotherapy: a multi-country approach. |
| Author(s): Duran A1, Spaepen E2, Lamotte M3, Walter E4, Lucioni C5, Pinheiro B6, Brosa M7, Kutikova L8, Pujol B8, Annemans L9 |
| Affiliations(s): 1 IMS Health, London, United Kingdom 2 SBD Analytics, Belgium 3 IMS Health, Vilvoorde, Belgium 4 Institute for Parmacoeconomic Research, Vienna, Austria 5 Wolters Kluwer Health Italy, Milan, Italy 6 Centre de Investigaçao Sobre Economia Portuguesa, Lisboa, Portugal 7 Oblikue Consulting, Barcelona, Spain 8 Amgen (Europe), Zug, Switzerland 9 I-CHER Interuniversity Centre for Health Economics Research, Gent, Belgium |
| Publication(s): ISPOR 14th Annual European Congress
5-8 November 2011, Madrid, Spain
|
| Document Type(s): Poster |
| Countries: Austria, Italy, Portugal, Spain |
C:
Y: |
Oncology
2011 |
|
L:
A: |
English
Cost analysis |
|
|
| |
| |
| Modeling cost-effectiveness of drug treatments for severe chronic non-cancer pain in Portugal |
| Author(s): Obradovic M1, Hertel N2, Ikenberg R3, Gouveia M4, Liedgens H1
|
| Affiliations(s): 1Grünenthal GmbH, Aachen, Germany, 2IMS Health, London, UK, 3IMS Health GmbH Und Co. Ohg, Nürnberg, Germany, 4Catholic University of Portugal, Lisbon, Portugal |
| Publication(s): ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain
|
| Document Type(s): Poster |
| Countries: Portugal |
| Click here for the abstract |
C:
Y: |
Neurological disorders
2011 |
|
L:
A: |
English
Cost effectiveness |
|
|
| |
| |
| Cost-effectiveness of transferring Type-2 Diabetic patients from Neutral Protamine Hagedorn (NPH) To Detemir in Portugal settings |
| Author(s): Carvalho D1, Lindner L2, Kozarzewski M3 |
| Affiliations(s): 1São João Hospital, Porto, Porto, Portugal, 2IMS Health, Barcelona, Cataluña, Spain, 3Novo Nordisk Portugal, Lisboa, Lisboa, Portugal |
| Publication(s): ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain
|
| Document Type(s): Poster |
| Countries: Portugal |
| Click here for the abstract |
C:
Y: |
Diabetes
2011 |
|
L:
A: |
English
Cost effectiveness |
|
|
| |
| |
 1 of 2 
|
|
